James Stankiewicz

1.3k total citations
27 papers, 960 citations indexed

About

James Stankiewicz is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, James Stankiewicz has authored 27 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 10 papers in Neurology and 8 papers in Oncology. Recurrent topics in James Stankiewicz's work include Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (10 papers) and Polyomavirus and related diseases (8 papers). James Stankiewicz is often cited by papers focused on Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (10 papers) and Polyomavirus and related diseases (8 papers). James Stankiewicz collaborates with scholars based in United States, Poland and Italy. James Stankiewicz's co-authors include Rohit Bakshi, Ashish Arora, Mohit Neema, Howard L. Weiner, Courtney E. Batt, S. Scott Panter, Brian C. Healy, Charles R.G. Guttmann, Guy J. Buckle and Maria K. Houtchens and has published in prestigious journals such as Neurology, The American Journal of Medicine and Neuroreport.

In The Last Decade

James Stankiewicz

26 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Stankiewicz United States 16 584 253 221 161 143 27 960
Jacqueline Durfee United States 12 510 0.9× 178 0.7× 177 0.8× 151 0.9× 164 1.1× 14 743
Channa Kolb United States 21 807 1.4× 301 1.2× 159 0.7× 134 0.8× 199 1.4× 50 1.2k
Zhaleh Khaleeli United Kingdom 19 892 1.5× 277 1.1× 302 1.4× 104 0.6× 271 1.9× 27 1.1k
Eva Strijbis Netherlands 17 674 1.2× 231 0.9× 114 0.5× 145 0.9× 108 0.8× 98 1.0k
Philipp Eisele Germany 18 474 0.8× 242 1.0× 263 1.2× 168 1.0× 64 0.4× 63 961
Svetlana Egorova United States 15 322 0.6× 179 0.7× 169 0.8× 247 1.5× 92 0.6× 24 963
Reem F. Bunyan Saudi Arabia 8 760 1.3× 273 1.1× 108 0.5× 152 0.9× 172 1.2× 23 1.0k
Robert Glanzman United States 9 529 0.9× 354 1.4× 98 0.4× 101 0.6× 128 0.9× 14 1.1k
Timo Uphaus Germany 18 308 0.5× 218 0.9× 92 0.4× 190 1.2× 48 0.3× 53 952
Benjamin Knier Germany 18 598 1.0× 277 1.1× 91 0.4× 138 0.9× 247 1.7× 37 1.1k

Countries citing papers authored by James Stankiewicz

Since Specialization
Citations

This map shows the geographic impact of James Stankiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Stankiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Stankiewicz more than expected).

Fields of papers citing papers by James Stankiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Stankiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Stankiewicz. The network helps show where James Stankiewicz may publish in the future.

Co-authorship network of co-authors of James Stankiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of James Stankiewicz. A scholar is included among the top collaborators of James Stankiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Stankiewicz. James Stankiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Williams, Mitzi, Lilyana Amezcua, Stanley Cohan, et al.. (2024). Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups. Neurology. 103(3). e209610–e209610. 3 indexed citations
3.
Bar‐Or, Amit, Ángel Chinea, Barry Hendin, et al.. (2023). Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab. Multiple Sclerosis and Related Disorders. 79. 104967–104967. 3 indexed citations
4.
Álvarez, Enrique, Erin E. Longbrake, Kottil Rammohan, James Stankiewicz, & Carrie M. Hersh. (2023). Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management. Multiple Sclerosis and Related Disorders. 79. 105009–105009. 26 indexed citations
5.
Sattarnezhad, Neda, Brian C. Healy, Moogeh Baharnoori, et al.. (2022). Comparison of dimethyl fumarate and interferon outcomes in an MS cohort. BMC Neurology. 22(1). 252–252. 5 indexed citations
6.
Kimbrough, Dorlan, et al.. (2020). A possible case of serum sickness after ocrelizumab infusion. Multiple Sclerosis Journal. 27(1). 155–158. 9 indexed citations
7.
Stankiewicz, James & Howard L. Weiner. (2019). An argument for broad use of high efficacy treatments in early multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(1). 54 indexed citations
8.
Meredith, David M., et al.. (2019). Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab. Neurology Neuroimmunology & Neuroinflammation. 6(5). 9 indexed citations
9.
Matiello, Marcelo, et al.. (2018). Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients. Journal of Neurology. 265(11). 2688–2694. 13 indexed citations
10.
Zurawski, Jonathan & James Stankiewicz. (2017). Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts. The American Journal of Medicine. 131(5). 464–472. 16 indexed citations
11.
Bakshi, Rohit, Mohit Neema, Shahamat Tauhid, et al.. (2014). An expanded composite scale of MRI-defined disease severity in multiple sclerosis. Neuroreport. 25(14). 1156–1161. 20 indexed citations
12.
Stankiewicz, James, Hadar Kolb, Arnon Karni, & Howard L. Weiner. (2012). Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis. Neurotherapeutics. 10(1). 77–88. 27 indexed citations
13.
Cohen, Adam B., Mohit Neema, Ashish Arora, et al.. (2011). The Relationships among MRI‐Defined Spinal Cord Involvement, Brain Involvement, and Disability in Multiple Sclerosis. Journal of Neuroimaging. 22(2). 122–128. 79 indexed citations
14.
Klein, Jan, Ashish Arora, M. Neema, et al.. (2011). A 3T MR Imaging Investigation of the Topography of Whole Spinal Cord Atrophy in Multiple Sclerosis. American Journal of Neuroradiology. 32(6). 1138–1142. 39 indexed citations
15.
Stankiewicz, James, M. Neema, David C. Alsop, et al.. (2009). Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study. Journal of the Neurological Sciences. 279(1-2). 99–105. 61 indexed citations
16.
Stankiewicz, James, Bonnie I. Glanz, Brian C. Healy, et al.. (2009). Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis. Journal of Neuroimaging. 21(2). e50–e56. 90 indexed citations
17.
Neema, M., Zachary D. Guss, James Stankiewicz, et al.. (2009). Normal Findings on Brain Fluid-Attenuated Inversion Recovery MR Images at 3T. American Journal of Neuroradiology. 30(5). 911–916. 54 indexed citations
18.
Gauthier, Susan A., Bonnie I. Glanz, Micha Mandel, et al.. (2009). Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study. Journal of the Neurological Sciences. 284(1-2). 116–119. 22 indexed citations
19.
Bakshi, Rohit, Mohit Neema, Brian C. Healy, et al.. (2008). Predicting Clinical Progression in Multiple Sclerosis With the Magnetic Resonance Disease Severity Scale. Archives of Neurology. 65(11). 1449–1449. 40 indexed citations
20.
Stankiewicz, James, S. Scott Panter, Mohit Neema, et al.. (2007). Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications. Neurotherapeutics. 4(3). 371–386. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacqueline Durfee Breakdown of academic impact, for papers by Channa Kolb Breakdown of academic impact, for papers by Zhaleh Khaleeli Breakdown of academic impact, for papers by Eva Strijbis Breakdown of academic impact, for papers by Philipp Eisele Breakdown of academic impact, for papers by Svetlana Egorova Breakdown of academic impact, for papers by Reem F. Bunyan Breakdown of academic impact, for papers by Robert Glanzman Breakdown of academic impact, for papers by Timo Uphaus Breakdown of academic impact, for papers by Benjamin Knier
Rankless by CCL
2026